Taribavirin
Taribavirin is an oral, liver-targeting inhibitor of inosine monophosphate dehydrogenase (IMPDH) developed for hepatitis C virus (HCV) research. Its design aims to minimize red blood cell distribution, thereby reducing the risk of hemolytic anemia in experimental models, making it a tool for studying antiviral mechanisms in vitro and in vivo.
Product Specifications
CAS Number
119567-79-2
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
O[C@H]1[C@@H] (O[C@H] (CO) [C@H]1O) N2N=C (C (=N) N) N=C2
Molecular Formula
C8H13N5O4
Molecular Weight
243.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037307-ML405 100 µL
KCND3, NT (KCND3, Potassium voltage-gated channel subfamily D member 3, Voltage-gated potassium channel subunit Kv4.3) (MaxLight 405) discontinued
Sign In for Pricing
View Details 